IRIS
FILIPPI, ANDREA RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.455
EU - Europa 718
AS - Asia 160
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 2.338
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.435
IE - Irlanda 564
CN - Cina 148
IT - Italia 50
FI - Finlandia 45
CA - Canada 20
DE - Germania 20
SE - Svezia 16
BE - Belgio 9
IN - India 5
NL - Olanda 5
VN - Vietnam 4
EU - Europa 3
HK - Hong Kong 3
RU - Federazione Russa 3
GB - Regno Unito 2
GR - Grecia 2
FR - Francia 1
MU - Mauritius 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 2.338
Salva come PNG Salva come JPEG
Città #
Dublin 561
Chandler 345
Ashburn 255
Princeton 117
Lawrence 99
Medford 81
Beijing 77
Wilmington 64
Shanghai 60
Washington 49
Helsinki 45
New York 20
Norwalk 17
Toronto 17
Ann Arbor 16
Pavia 14
Saint Louis 10
Brussels 9
Los Angeles 9
Redwood City 6
Canyon Country 5
Falkenstein 5
Houston 5
Dong Ket 4
Milan 4
Pune 4
Seattle 4
Chicago 3
Cork 3
Maastricht 3
Malo 3
Torino 3
Bronx 2
Brunssum 2
Buccinasco 2
Castel del Giudice 2
Ferentino 2
Naples 2
Ottawa 2
Palo del Colle 2
San Jose 2
Villanuova sul Clisi 2
Wuhan 2
Borås 1
Brescia 1
Brugherio 1
Carate 1
Chengdu 1
Fairfield 1
Florence 1
Guangzhou 1
Haikou 1
Hanover 1
Johannesburg 1
Leawood 1
Monmouth Junction 1
Montreal 1
Mountain View 1
Myszkow 1
Nanchang 1
Piateda 1
Redmond 1
Shenzhen 1
Tappahannock 1
Woodbridge 1
Xining 1
Totale 1.962
Salva come PNG Salva come JPEG
Nome #
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 48
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 48
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG 46
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 42
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study 42
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 41
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 41
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 39
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 38
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 37
Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiation therapy 36
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 36
COVID-19 OUTBREAK IN NORTHERN ITALY: FIRST PRACTICAL INDICATIONS FOR RADIOTHERAPY DEPARTMENTS 35
Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: Cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple noncoplanar arcs 35
To a new normal in radiation oncology: looking back and planning forward 35
The prognostic impact of BIA-derived fat-free mass index in patients with cancer 35
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 34
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 34
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 33
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center “Blue Sky Radiomics” study on stage III unresectable NSCLC 33
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy 31
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 31
Current role and future developments of radiotherapy in Hodgkin's lymphoma 30
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations 30
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 30
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 30
Definitive radiotherapy for localized follicular lymphoma staged by18F-FDG PET-CT: A collaborative study by ILROG 29
PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy 29
Radiotherapy in Pediatric Oncology 29
Brain metastases from lung cancer: Is MET an actionable target? 29
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 29
The 8th UICC/AJCC TNM edition for non-small cell lung cancer staging: getting off to a flying start? 28
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum 27
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study 27
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 27
Extranodal Marginal Zone Lymphoma 26
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease 26
Treatment of metastatic melanoma: a multidisciplinary approach 26
COVID-19: Global radiation oncology's targeted response for pandemic preparedness 26
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA 26
Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy 25
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation 25
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia 25
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 24
Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma 24
Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases 24
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 24
Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach 23
A Strategy for Young Members within National Radiation Oncology Societies: the Italian Experience (AIRO Giovani Group) 23
Radiomics features as predictive and prognostic biomarkers in NSCLC 22
The "BUONGIORNO" Project: Burnout Syndrome Among Young Italian Radiation Oncologists 21
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC 20
Emo-linfopatie maligne 20
Is clinical radiosensitivity a complex genetically controlled event? 20
New concepts and insights into the role of radiation therapy in extracranial metastatic disease 20
Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis 20
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: a systematic review 20
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study 19
Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins 19
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 19
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 18
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 18
Stereotactic Ablative Radiation Therapy as First Local Therapy for Lung Oligometastases From Colorectal Cancer: A Single-Institution Cohort Study 18
Stereotactic radiotherapy for early stage non-small cell lung cancer 18
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 18
Limited stage follicular lymphoma: Current role of radiation therapy 18
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 18
Radiation therapy for older patients with brain tumors 17
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer 17
Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience 17
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 16
Innovative technologies in thoracic radiation therapy for lung cancer 16
Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer 15
Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy 15
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 15
Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases 15
Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Lymphoma Radiation Oncology Group 15
Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients 15
Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation 15
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 15
Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG) 14
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists 14
Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma 14
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients 14
Intensity Modulated Radiation Therapy and Second Cancer Risk in Adults 14
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 14
Optimal Therapy for Early-Stage Hodgkin’s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy 14
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 13
Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies 13
What do radiation oncologists require for future advancements in lung SBRT? 13
Interim PET and clinical outcome in early stage Hodgkin’s Lymphoma patients treated with combined modality therapy 13
Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases 13
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 12
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 12
Radiomics features as predictive and prognostic biomarkers in NSCLC 12
Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation 12
Radiotherapy and immune checkpoints inhibitors for advanced melanoma 12
Renewed interest for low-dose radiation therapy in follicular lymphomas: From biology to clinical applications 12
Stereotactic body radiotherapy for early stage lung cancer: History and updated role 12
Treatment options in skeletal localizations of hairy cell leukemia: A systematic review on the role of radiation therapy 11
Totale 2.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020165 0 0 0 0 1 1 2 3 87 27 43 1
2020/202175 0 11 1 7 0 2 6 11 4 1 1 31
2021/2022417 16 0 19 6 7 9 9 29 24 9 68 221
2022/20231.184 136 51 5 75 71 99 5 67 626 4 40 5
2023/2024629 64 71 74 41 76 203 63 12 1 23 1 0
Totale 2.470